Compare OSRH & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OSRH | AIMD |
|---|---|---|
| Founded | N/A | 1984 |
| Country | United States | United States |
| Employees | 21 | 44 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7M | 9.8M |
| IPO Year | N/A | N/A |
| Metric | OSRH | AIMD |
|---|---|---|
| Price | $0.55 | $1.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 707.2K | 20.1K |
| Earning Date | 05-19-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.38 | $0.44 |
| 52 Week High | $2.72 | $4.50 |
| Indicator | OSRH | AIMD |
|---|---|---|
| Relative Strength Index (RSI) | 52.16 | 45.71 |
| Support Level | $0.39 | $1.33 |
| Resistance Level | $0.74 | $1.72 |
| Average True Range (ATR) | 0.06 | 0.11 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 50.22 | 30.16 |
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.